C101H125F7N30O7 — CID 158826187
6-(cyclobutylmethyl)-1-(1-methylpiperidin-3-yl)-5H-pyrazolo[5,4-d]pyrimidin-4-one;6-(cyclobutylmethyl)-1-(1-methylpyrrolidin-3-yl)-5H-pyrazolo[5,4-d]pyrimidin-4-one;6-[(2-fluorophenyl)methyl]-1-(1-methylpiperidin-3-yl)-5H-pyrazolo[5,4-d]pyrimidin-4-one;6-[(2-methoxyphenyl)methyl]-1-(1-methylpyrrolidin-3-yl)-5H-pyrazolo[5,4-d]pyrimidin-4-one;1-(1-methylpiperidin-3-yl)-6-[[3-(trifluoromethyl)phenyl]methyl]-5H-pyrazolo[5,4-d]pyrimidin-4-one;1-(1-methylpyrrolidin-3-yl)-6-[2-(trifluoromethyl)butyl]-5H-pyrazolo[5,4-d]pyrimidin-4-one (PubChem CID 158826187) has the molecular formula C101H125F7N30O7 and a molecular weight of 2004.30 g/mol. Its IUPAC name is 6-(cyclobutylmethyl)-1-(1-methylpiperidin-3-yl)-5H-pyrazolo[5,4-d]pyrimidin-4-one;6-(cyclobutylmethyl)-1-(1-methylpyrrolidin-3-yl)-5H-pyrazolo[5,4-d]pyrimidin-4-one;6-[(2-fluorophenyl)methyl]-1-(1-methylpiperidin-3-yl)-5H-pyrazolo[5,4-d]pyrimidin-4-one;6-[(2-methoxyphenyl)methyl]-1-(1-methylpyrrolidin-3-yl)-5H-pyrazolo[5,4-d]pyrimidin-4-one;1-(1-methylpiperidin-3-yl)-6-[[3-(trifluoromethyl)phenyl]methyl]-5H-pyrazolo[5,4-d]pyrimidin-4-one;1-(1-methylpyrrolidin-3-yl)-6-[2-(trifluoromethyl)butyl]-5H-pyrazolo[5,4-d]pyrimidin-4-one.
| Compound Name | 6-(cyclobutylmethyl)-1-(1-methylpiperidin-3-yl)-5H-pyrazolo[5,4-d]pyrimidin-4-one;6-(cyclobutylmethyl)-1-(1-methylpyrrolidin-3-yl)-5H-pyrazolo[5,4-d]pyrimidin-4-one;6-[(2-fluorophenyl)methyl]-1-(1-methylpiperidin-3-yl)-5H-pyrazolo[5,4-d]pyrimidin-4-one;6-[(2-methoxyphenyl)methyl]-1-(1-methylpyrrolidin-3-yl)-5H-pyrazolo[5,4-d]pyrimidin-4-one;1-(1-methylpiperidin-3-yl)-6-[[3-(trifluoromethyl)phenyl]methyl]-5H-pyrazolo[5,4-d]pyrimidin-4-one;1-(1-methylpyrrolidin-3-yl)-6-[2-(trifluoromethyl)butyl]-5H-pyrazolo[5,4-d]pyrimidin-4-one |
|---|---|
| PubChem CID | 158826187 |
| Molecular Formula | C101H125F7N30O7 |
| Molecular Weight | 2004.30 g/mol |
| Exact Mass | 2003.02 |
| IUPAC Name | 6-(cyclobutylmethyl)-1-(1-methylpiperidin-3-yl)-5H-pyrazolo[5,4-d]pyrimidin-4-one;6-(cyclobutylmethyl)-1-(1-methylpyrrolidin-3-yl)-5H-pyrazolo[5,4-d]pyrimidin-4-one;6-[(2-fluorophenyl)methyl]-1-(1-methylpiperidin-3-yl)-5H-pyrazolo[5,4-d]pyrimidin-4-one;6-[(2-methoxyphenyl)methyl]-1-(1-methylpyrrolidin-3-yl)-5H-pyrazolo[5,4-d]pyrimidin-4-one;1-(1-methylpiperidin-3-yl)-6-[[3-(trifluoromethyl)phenyl]methyl]-5H-pyrazolo[5,4-d]pyrimidin-4-one;1-(1-methylpyrrolidin-3-yl)-6-[2-(trifluoromethyl)butyl]-5H-pyrazolo[5,4-d]pyrimidin-4-one |
| SMILES | CCC(Cc1nc2c(cnn2C2CCN(C)C2)c(=O)[nH]1)C(F)(F)F.CN1CCC(n2ncc3c(=O)[nH]c(CC4CCC4)nc32)C1.CN1CCCC(n2ncc3c(=O)[nH]c(CC4CCC4)nc32)C1.CN1CCCC(n2ncc3c(=O)[nH]c(Cc4cccc(C(F)(F)F)c4)nc32)C1.CN1CCCC(n2ncc3c(=O)[nH]c(Cc4ccccc4F)nc32)C1.COc1ccccc1Cc1nc2c(cnn2C2CCN(C)C2)c(=O)[nH]1 |
| InChI | InChI=1S/C19H20F3N5O.C18H20FN5O.C18H21N5O2.C16H23N5O.C15H20F3N5O.C15H21N5O/c1-26-7-3-6-14(11-26)27-17-15(10-23-27)18(28)25-16(24-17)9-12-4-2-5-13(8-12)19(20,21)22;1-23-8-4-6-13(11-23)24-17-14(10-20-24)18(25)22-16(21-17)9-12-5-2-3-7-15(12)19;1-22-8-7-13(11-22)23-17-14(10-19-23)18(24)21-16(20-17)9-12-5-3-4-6-15(12)25-2;1-20-7-3-6-12(10-20)21-15-13(9-17-21)16(22)19-14(18-15)8-11-4-2-5-11;1-3-9(15(16,17)18)6-12-20-13-11(14(24)21-12)7-19-23(13)10-4-5-22(2)8-10;1-19-6-5-11(9-19)20-14-12(8-16-20)15(21)18-13(17-14)7-10-3-2-4-10/h2,4-5,8,10,14H,3,6-7,9,11H2,1H3,(H,24,25,28);2-3,5,7,10,13H,4,6,8-9,11H2,1H3,(H,21,22,25);3-6,10,13H,7-9,11H2,1-2H3,(H,20,21,24);9,11-12H,2-8,10H2,1H3,(H,18,19,22);7,9-10H,3-6,8H2,1-2H3,(H,20,21,24);8,10-11H,2-7,9H2,1H3,(H,17,18,21) |
| InChIKey | IWMGQWBCJLETGA-UHFFFAOYSA-N |
| XLogP | 11.90 |
| TPSA | 410.09 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 31 |
| Rotatable Bonds | 20 |
| Heavy Atoms | 145 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2004.30 |
| LogP ≤ 5 | 11.90 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 31 |